The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortality

International Journal of Cardiology

Volumn 146, Issue 3, 2011, Pages 431-

  Lin, Gen Min ^a   Chu, Kai Min ^b   Han, Chih Lu ^c  

^a HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular risk; Inflammation; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; MORTALITY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78951472563     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.101     Document Type: Article

References (7)

1. S. Mottillo, K.B. Filion, and J. Genest The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
2. Ridker P.M., Danielson E., and Fonseca F.A. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
3. R.J. Glynn, W. Koenig, B.G. Nordestgaard, J. Shepherd, and P.M. Ridker Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial Ann Intern Med 152 2010 488 496
4. S. Mora, R.J. Glynn, J. Hsia, J.G. MacFadyen, J. Genest, and P.M. Ridker Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials Circulation 121 2010 1069 1077
5. Y. Aizawa, N. Kamimura, and H. Watanabe Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence Int J Cardiol 109 2006 213 218
6. V.Z. Rocha, and P. Libby Obesity, inflammation, and atherosclerosis Nat Rev Cardiol 6 2009 399 409
7. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2